Index by author

February 1, 2024; Volume 65,Issue 2

  1. Falkenhorst, Johanna

    1. Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor
      Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor
      Rainer Hamacher, Kim M. Pabst, Phyllis F. Cheung, Christoph E. Heilig, Jennifer Hüllein, Sven-Thorsten Liffers, Sabrina Borchert, Pedro Fragoso Costa, Benedikt M. Schaarschmidt, Lukas Kessler, Monika A. Miera, Margret Droste, Merve Akbulut, Johanna Falkenhorst, Fadi Zarrad, Karina Kostbade, Ilektra A. Mavroeidi, Hanno Glimm, Lale Umutlu, Martin Schuler, Daniel Hübschmann, Sebastian Bauer, Stefan Fröhling, Ken Herrmann, Jens T. Siveke, Hans-Ulrich Schildhaus and Wolfgang P. Fendler
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 252-257; DOI: https://doi.org/10.2967/jnumed.123.266411

  2. Fendler, Wolfgang P.

    1. Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor
      Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor
      Rainer Hamacher, Kim M. Pabst, Phyllis F. Cheung, Christoph E. Heilig, Jennifer Hüllein, Sven-Thorsten Liffers, Sabrina Borchert, Pedro Fragoso Costa, Benedikt M. Schaarschmidt, Lukas Kessler, Monika A. Miera, Margret Droste, Merve Akbulut, Johanna Falkenhorst, Fadi Zarrad, Karina Kostbade, Ilektra A. Mavroeidi, Hanno Glimm, Lale Umutlu, Martin Schuler, Daniel Hübschmann, Sebastian Bauer, Stefan Fröhling, Ken Herrmann, Jens T. Siveke, Hans-Ulrich Schildhaus and Wolfgang P. Fendler
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 252-257; DOI: https://doi.org/10.2967/jnumed.123.266411

  3. Feng, Runhua

    1. Value of <sup>68</sup>Ga-FAPI-04 and <sup>18</sup>F-FDG PET/CT in Early Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer
      Value of 68Ga-FAPI-04 and 18F-FDG PET/CT in Early Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer
      Ying Miao, Runhua Feng, Teng Yu, Rui Guo, Min Zhang, Yue Wang, Wangxi Hai, Chengfang Shangguan, Zhenggang Zhu and Biao Li
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 213-220; DOI: https://doi.org/10.2967/jnumed.123.266403

  4. Fettahoglu, Ates

    1. Early-Frame [<sup>18</sup>F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [<sup>15</sup>O]Water Gold Standard
      Early-Frame [18F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [15O]Water Gold Standard
      Ates Fettahoglu, Moss Zhao, Mehdi Khalighi, Hillary Vossler, Maria Jovin, Guido Davidzon, Michael Zeineh, Fernando Boada, Elizabeth Mormino, Victor W. Henderson, Michael Moseley, Kevin T. Chen and Greg Zaharchuk
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 306-312; DOI: https://doi.org/10.2967/jnumed.123.266273

  5. Fizazi, Karim

    1. Design Considerations in the PSMAfore Trial
      Oliver Sartor, Karim Fizazi, Ken Herrmann and Michael J. Morris
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 226-227; DOI: https://doi.org/10.2967/jnumed.123.267034

  6. Flamen, Patrick

    1. [<sup>18</sup>F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
      Open Access
      [18F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
      David L. Chan, Aimee R. Hayes, Ioannis Karfis, Alice Conner, Magdalena Mileva, Elizabeth Bernard, Geoffrey Schembri, Shaunak Navalkissoor, Gopinath Gnanasegaran, Nick Pavlakis, Clémentine Marin, Bruno Vanderlinden, Patrick Flamen, Paul Roach, Martyn E. Caplin, Christos Toumpanakis and Dale L. Bailey
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 185-191; DOI: https://doi.org/10.2967/jnumed.123.266346
    2. Prediction of <sup>177</sup>Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
      Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
      Magdalena Mileva, Gwennaëlle Marin, Hugo Levillain, Carlos Artigas, Camille Van Bogaert, Clémentine Marin, Rachele Danieli, Amelie Deleporte, Simona Picchia, Konstantinos Stathopoulos, Christiane Jungels, Bruno Vanderlinden, Marianne Paesmans, Lieveke Ameye, Gabriela Critchi, Loubna Taraji-Schiltz, Chloe Velghe, Zéna Wimana, Maria Bali, Alain Hendlisz, Patrick Flamen and Ioannis Karfis
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 236-244; DOI: https://doi.org/10.2967/jnumed.123.265987

  7. Fontaine, Christel

    1. Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma
      Open Access
      Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma
      Odrade Gondry, Vicky Caveliers, Catarina Xavier, Laurens Raes, Marian Vanhoeij, Guy Verfaillie, Christel Fontaine, Katrien Glorieus, Jacques De Grève, Sofie Joris, Ine Luyten, Karen Zwaenepoel, Frederik Vandenbroucke, Wim Waelput, Sheeno Thyparambil, Ilse Vaneycken, Julie Cousaert, Sophie Bourgeois, Nick Devoogdt, Lode Goethals, Hendrik Everaert, Frank De Geeter, Tony Lahoutte and Marleen Keyaerts
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 178-184; DOI: https://doi.org/10.2967/jnumed.123.266254

  8. Fowler, Amy

    1. Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17β-Estradiol PET
      David Mankoff, Soňa Balogová, Lisa Dunnwald, Farrokh Dehdashti, Erik DeVries, Laura Evangelista, Michel Van Kruchten, Sofia Carrilho Vaz, Amy Fowler, Hannah Linden and Gary A. Ulaner
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 221-223; DOI: https://doi.org/10.2967/jnumed.123.266938

  9. Fraioli, Francesco

    1. Theranostics in Neurooncology: Heading Toward New Horizons
      Nelleke Tolboom, Antoine Verger, Nathalie L. Albert, Francesco Fraioli, Eric Guedj, Tatjana Traub-Weidinger, Silvia Morbelli, Ken Herrmann, Pietro Zucchetta, Sabine L.A. Plasschaert, Igor Yakushev, Michael Weller, Martin Glas, Matthias Preusser, Diego Cecchin, Henryk Barthel and Donatienne Van Weehaeghe
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 167-173; DOI: https://doi.org/10.2967/jnumed.123.266205

  10. Freitag, Martin T.

    1. Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis
      Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis
      Liene Friebe, Martin T. Freitag, Martin Braun, Guillaume Nicolas, Andreas Bauman, David Bushnell, Emanuel Christ and Damian Wild
      Journal of Nuclear Medicine February 1, 2024, 65 (2) 228-235; DOI: https://doi.org/10.2967/jnumed.123.265894
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue